SHR-4610
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 10, 2025
SHR-4610-101: A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=258 | Recruiting | Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Solid Tumor
1 to 1
Of
1
Go to page
1